Dr. Anat Aharon

Director, Hematology Research Laboratory, Tel Aviv medical center


Clinical experience

2/2018- Director, Hematology Research Laboratory, Tel Aviv medical center

2004-1/2018  Director, Microvesicle Research Laboratory, Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus 

2016- 1/2018  Member of the Clinical Research Institute at Rambam (CRIR)

2012-2014 CEO (50%), MPT Ltd. MPT Ltd – Micro-Particles technology - dedícate to bringing a  simple, eficiente and cost effective blood test of the mother for prenatal genetic testing

2002-04 Beth Israel Deaconess Medical Center, Boston, MA, USA,  Postdoctoral fellowship

2000-02 Bruce Rappaport Medical School, Technion, Israel's Institute of Technology. Haifa, Israel,  Instructor, Hematology for medicine students.


Academic experience

2019-Present Senior Lecturer,  faculty of medicine, Tel Aviv University 

20015-2018 Assistant  Professor , Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of  Technology, Haifa, Israel

2010-201  Associated Senior Lecturer faculty of medicine – Technion, Israel`s Institute of   Technology, Haifa, Israel 

2005-2010  Associated lecture faculty of medicine, Technion, Israel`s Institute of Technology, Haifa, Israel

Prizes and achivements

2011  The 2011 Rambam Medical Center Research Award, for the study "Microparticles effect on Apoptosis, Angiogenesis and Migration in Healthy and Pathological Pregnancies".

2005  Aventis/ ISTH thrombosis research - fellowship award for basic research. "The role of microparticles in gestational vascular complications (GVC) and their possible modulation by enoxaparin"

2002 The Boston-Haifa Research Award for the study "Characterization and   function of microparticles in the placenta’s local haemostatic balance by - in vitro and in vivo models."

2001 The 2001 Rambam Medical Center Research Award, for the study "Procoagulant and anti coagulant mechanisms in human placenta."

Union membership

ISTH-International Society on Thrombosis and Haemostasis, Inc

European and Mediterranean League against Thrombotic Diseases -EMLTD

ISEV- The International Society for Extracellular Vesicles

Hematologic Society Israel 

AACR - American Association for Cancer Research


Areas of interest

​Extracellular Vesicles (EVs) are small (≈1 µm) cellular membrane vesicles shed from various cells upon stimulation or apoptosis. EVs are found in blood of healthy individuals and their levels increase in a variety of diseases (cancer, diabetes, vascular diseases, etc.). EVs are involved in physiological processes but they can also promote pathological states. Over the last 15 years Dr. Aharon and her team have studied the role of EVs in healthy persons and in patient with gestational vascular complications, diabetes vascular complications, cancer (hematological malignancies: myeloma, AML, ALL and solid tumors such as breast cancer, colon cancer), in congenital disorders such as thalassemia and in trauma patients and patients with dementia. Furthermore, the effects of EVs that are shed from cell culture upon stimulation on functionality of endothelial cells as well as placental cells, liver, pancreatic and breast cancer cell lines were explored. Additionally the therapeutic potential of EVs in chronic GVHD is currently being invested